LA JOLLA PHARMACEUTICAL CO Insider Trading for July 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for July 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.24 | 203 | 1,876 | 203 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.85 | 203 | 1,594 | 2,997 | 2.8 K to 3 K (+7.27 %) |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.24 | 203 | 1,876 | 203 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.85 | 203 | 1,594 | 1,724 | 1.5 K to 1.7 K (+13.35 %) |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.24 | 102 | 942 | 102 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.85 | 102 | 801 | 78,723 | 78.6 K to 78.7 K (+0.13 %) |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.24 | 73 | 675 | 73 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.85 | 73 | 573 | 6,057 | 6 K to 6.1 K (+1.22 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.25 | 202 | 1,869 | 202 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.86 | 202 | 1,588 | 2,794 | 2.6 K to 2.8 K (+7.79 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.25 | 101 | 934 | 101 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.86 | 101 | 794 | 78,621 | 78.5 K to 78.6 K (+0.13 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.25 | 202 | 1,869 | 202 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.86 | 202 | 1,588 | 1,521 | 1.3 K to 1.5 K (+15.31 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.25 | 73 | 675 | 73 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.86 | 73 | 574 | 5,984 | 5.9 K to 6 K (+1.23 %) |